Patents by Inventor Chun Young LEE

Chun Young LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211762
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of sepsis or systemic inflammatory response syndrome (SIRS) comprising mitochondria as effective ingredient. When activated macrophages and monocytes are treated with mitochondria which are effective ingredient of the pharmaceutical composition of the present invention, expression of IL-1?, TNF-? and IL-6 which are pro-inflammatory cytokines can be restored to normal levels. Furthermore, when the pharmaceutical composition of the present invention is administered to a subject suffering from sepsis, the survival rate of the subject can be remarkably increased. Therefore, the pharmaceutical composition according to the present invention can be useful for the treatment of sepsis.
    Type: Application
    Filed: April 27, 2020
    Publication date: July 7, 2022
    Inventors: Kyuboem HAN, Chun-Hyung KIM, Shin-Hye YU, Seo-Eun LEE, Sang-Min LIM, Hahnsun JUNG, Kwangmin NA, Yoon Mi HAN, Jun Young SON, Jong-Cheon HA, Kyunghee JUNG, Young-Cheol KANG, Eun-Seo LEE, Mi Jin KIM, Yong-Soo CHOI, Jung Uk HWANG, Min Ji LEE, Kyuseok KIM, Tae Nyoung CHUNG
  • Publication number: 20220211754
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating myositis. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating myositis, comprising mitochondria as an active ingredient. When the pharmaceutical composition of the present invention comprising exogenous mitochondria as an active ingredient is administered to a subject suffering from myositis, inflammatory cells infiltrated into the muscle cells of the subject can be reduced. In addition, the pharmaceutical composition of the present invention effectively inhibits the expression of IL-1?, TNF-?, and IL-6, inflammatory cytokines. Therefore, the pharmaceutical composition according to the present invention can be usefully used for preventing or treating myositis.
    Type: Application
    Filed: April 29, 2020
    Publication date: July 7, 2022
    Inventors: Kyuboem HAN, Chun-Hyung KIM, Shin-Hye YU, Seo-Eun LEE, Sang-Min LIM, Hahnsun JUNG, Kwangmin NA, Yoon Mi HAN, Jun Young SON, Eun Young LEE, Jeong Yeon KIM, Yeong Wook SONG, Jin Chul PAENG, Yun Sang LEE, Do Won HWANG
  • Patent number: 11374177
    Abstract: Provided are a compound represented by the following Chemical Formulas and an organic light emitting device comprising the same.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: June 28, 2022
    Inventors: Kwang Ju Jung, Sung Soo Kim, Hyun Young Yoo, Jong Jin Ha, Seok Jong Lee, Chun Young Lee
  • Publication number: 20200235309
    Abstract: Provided are a compound represented by the following Chemical Formulas and an organic light emitting device comprising the same.
    Type: Application
    Filed: November 7, 2019
    Publication date: July 23, 2020
    Inventors: Kwang Ju JUNG, Sung Soo KIM, Hyun Young YOO, Jong Jin HA, Seok Jong LEE, Chun Young LEE